What happens to the UK tax position in a Delaware flip?

When is a flip actually needed?

First, the prior question, because a fair number of founders flip without needing to. A Delaware corporation does not make a company investable. Flipping on spec costs money and adds complexity you cannot easily undo.

A Delaware flip is a share-for-share exchange that puts a US corporation on top of an existing UK company, which survives as a wholly owned subsidiary. The legal mechanics are well trodden and increasingly productised. The UK exposure is not in the mechanics. It is that four separate workstreams run off the same transaction. Capital gains, stamp duty, SEIS and EIS continuity, and EMI options each have their own conditions and their own deadlines, and several depend on things being done in a particular order.

In practice the flip becomes necessary when a US investor makes it a condition of investing. US venture counsel speaking on the SeedLegals channel put the proportion of US-led seed rounds requiring a flip at roughly three quarters to four fifths, falling to around a fifth to a quarter at Series A and close to none at Series B or later [1]. That is one practitioner's market observation rather than published research, so treat it as a rough shape. It broadly reflects how standardised a fund's documents are at each stage: the earlier the round, the less willing a fund is to depart from its own paper to accommodate a foreign holding company.

Most founders get to this point because the US has become the centre of gravity. Customers are there, or an investor is shaping the structure, or an accelerator has already left pieces of a US structure behind. The flip is one transaction inside that bigger decision.

What happens to shareholders on the exchange?

Shareholders exchange their UK shares for shares in the Delaware company. TCGA 1992 s 135 governs the UK treatment of a qualifying exchange, treating it as a reorganisation rather than a disposal, so no capital gains charge arises and the new shares stand in the shoes of the old, carrying across base cost and acquisition date.

Section 135 requires the acquiring company to obtain control of the target, or more than 25%, or to be acting on a general offer. In a flip the acquirer takes 100%, so the control condition is straightforward.

The anti-avoidance rule is s 137(1): s 135 does not apply unless the exchange is for bona fide commercial reasons and does not form part of arrangements with a main purpose of avoiding capital gains tax or corporation tax. Advance clearance that s 137 will not apply can be sought under s 138, and it is usually paired with a transactions in securities clearance under ITA 2007 s 701 confirming that no counteraction notice will be issued under s 698. HMRC has 30 days to respond, running from receipt of the application or of any further information it requests.

UK residence is central in the common case, but it is not the whole of the question. Shareholders resident elsewhere should check both their local treatment of the exchange and whether they retain any continuing UK exposure.

What does the HMRC clearance actually do?

Founders misread this letter in both directions, which is unusual for a tax document.

A s 138 clearance addresses whether HMRC will apply the s 137 anti-avoidance rule on the facts disclosed. It does not confirm that s 135 applies, nor that stamp duty relief or the EIS and SEIS share-exchange provisions apply. It can only be relied on where the application described all material facts fully and accurately. Founders who read the letter as a clean bill of health for the transaction are reading in a great deal that is not there.

Now the other direction. Advance s 138 clearance is itself one of the conditions for EIS and SEIS continuity where a new holding company is inserted [2]. The clearance does not certify that continuity applies, but continuity cannot apply without it. That is why the clearance belongs early in the sequence rather than wherever the lawyers reach it. The remaining conditions, including the subscriber-share and shares-only requirements, still have to be checked separately.

Do not confuse this with SEIS or EIS advance assurance. That is a different process about a fresh investment, and the two get mixed up in conversation more often than you would expect.

The HMRC clearance answers one narrow question about one anti-avoidance rule. It is not approval of the flip. But you still need it before the exchange, because your investors' SEIS and EIS relief depends on it having been obtained in advance.

Is stamp duty payable on a flip?

Often not, because acquisition relief under FA 1986 s 77 can remove the charge. Where relief is unavailable, the numbers are not trivial.

The flip transfers shares in a UK company by stock transfer form, which is a conveyance on sale. Consideration in the form of shares still counts: under Stamp Act 1891 s 55, where consideration consists of stock or marketable securities, duty is charged on the value of that stock. The rate is 0.5% of the value of the share consideration, rounded up to the nearest £5. Instruments should be presented within 30 days of execution to avoid interest and penalties. SDRT arises on the underlying agreement but is cancelled once the instrument is duly stamped.

To put some numbers on it, where the value of the share consideration is:

Acquisition relief under FA 1986 s 77 is available where the acquirer is a Delaware corporation. I still meet advisers who think it is not. The old condition requiring the acquiring company's registered office to be in the UK was omitted by Finance Act 2006 s 169, for instruments executed after that Act was passed on 19 July 2006 [3].

The conditions, broadly, are that the acquirer acquires the whole of the target's issued share capital; that the acquisition is for bona fide commercial reasons and not mainly for tax avoidance; that the consideration consists only of the issue of shares in the acquirer to the target's shareholders; and that the cap table mirrors, so that after the acquisition each person who was a shareholder in the target is a shareholder in the acquirer, with matching classes and proportions, or as nearly the same as may be. Relief is not automatic: the instrument must be adjudicated by HMRC's Stamp Office, and the standard claim requires confirmation that there are no disqualifying arrangements under s 77A [4].

In practice, two things cause most of the trouble.

The first is changes to the cap table at the flip. US deals often reshape the equity at the same moment, through new share classes, an option pool, founder reverse vesting or a different share count. Anything that breaks the mirror image can switch the relief off. This is why flips frequently include a pre-flip subdivision of the UK shares, so the UK structure already matches the intended Delaware structure before the exchange.

The second is a linked financing that engages s 77A. The question is whether arrangements existing when the transfer instrument is executed have as a purpose securing control of the new parent for a particular person, or particular persons together, taking account of the statutory definition and its exclusions. A round being planned alongside a flip does not by itself answer that question, and a minority venture round is not necessarily such an arrangement. What the proximity does affect is evidence: if s 77 relief fails, a contemporaneous round price may be strong evidence of the market value of the consideration shares at the date of the instrument. "Post-money valuation" is not the statutory charging measure, but it can inform the market value that is.

A scheme of arrangement avoids the charge differently, by cancelling the target shares and issuing new ones so there is no transfer to stamp. Companies Act 2006 s 641(2A) blocks reduction-of-capital schemes used for takeovers, with an exception for inserting a new holding company, though whether that exception operates where the new holding company is foreign does not appear to be settled, and court sanction makes schemes impractical at startup budgets. Treat it as a large-deal option.

What happens to SEIS and EIS relief?

EIS gives investors 30% income tax relief and SEIS gives 50%. On a £1m EIS round that is £300,000 of relief already claimed by people who backed the company before anyone else would, and it is withdrawn from them rather than from the company.

Continuity on a share exchange runs through ITA 2007 s 257HB for SEIS and s 247 for EIS. The conditions include that the new company, at the time of the exchange, has issued only subscriber shares; that the consideration is new shares only; that the new company acquires all the shares in the old company; that share classes and proportions mirror; that the exchange is for bona fide commercial reasons; and that HMRC has given the relevant s 138 clearance before the exchange.

Keep the Delaware entity clean until the swap. If it has already issued founder stock, or anything beyond subscriber shares, continuity is at risk. Incorporating the Delaware company early and putting equity into it feels like getting ahead of the work. It puts your investors' relief in question.

After the flip, the Delaware parent becomes the company that has to satisfy the ongoing qualifying conditions for the remainder of each investor's three-year period, including the UK permanent establishment requirement [9].

Then there is the next round. A US-style SAFE does not attract SEIS or EIS relief. HMRC accepts only advance subscription agreements meeting its own conditions, and preferential rights on the resulting shares, such as a guaranteed multiple on an exit occurring before a priced round, sit badly with the requirement that the shares carry no preferential rights. If UK angels are expected to participate in the next round, the instrument has to be designed with them in mind, or the flip will carefully preserve relief on the existing investment while the following round denies it on the new money.

What happens to the team's EMI options?

When the Delaware parent takes control, the UK company will normally stop meeting the EMI independence condition. That is generally a disqualifying event for its existing options. Two routes open up from there, and most of the commentary only mentions the second one.

If the option terms permit exercise, an employee can preserve the EMI tax advantages by exercising within 90 days of the disqualifying event.

If the options are instead to continue over shares in the Delaware parent, the parties can use the EMI replacement-option rules, provided all the conditions are met and the replacement is granted within six months of the acquirer obtaining control (ITEPA 2003 Sch 5 para 42). The replacement option must preserve the prescribed economic value and exercise price: the total market value of shares under option immediately after must equal the total immediately before, and the aggregate exercise price must be unchanged. The acquiring company must meet the applicable independence and trading-activity conditions, including the relevant UK permanent establishment condition. It does not have to meet the normal gross-assets or employee-number tests afresh at the replacement date [5].

If no qualifying replacement is made and an original option is exercised after the 90-day period, post-disqualifying-event growth can be charged as employment income, with National Insurance potentially applying where the statutory conditions are met, including where the shares are readily convertible assets. That is a narrower exposure than losing the whole gain, and it is still enough to matter to an employee who was told their gain would be taxed as capital.

The EMI limits changed in April 2026, which affects how the post-flip scheme is designed:

The requirement to notify EMI grants is also due to be removed for options granted on or after 6 April 2027 [6].

Underneath all of this sits a valuation problem. UK EMI valuations are agreed with HMRC's Shares and Assets Valuation team and are valid for 90 days from agreement, provided nothing changes the company's circumstances, and HMRC typically accepts material discounts for a minority holding in restricted, unlisted shares. The US has no EMI. A US equity incentive plan grants incentive stock options or non-qualified options, and the strike price must be at least fair market value determined under an IRC §409A valuation, which is independent, conventionally relied on for around twelve months or until a material event, and usually lands closer to the preferred round price than an HMRC EMI valuation would.

So UK and US employees end up holding options over the same stock at different strike prices. There is no clever fix for that. It is a decision about how value gets shared across two workforces, and whether US staff get more options to make up for a higher strike. Take it deliberately. The usual post-flip structure is a US equity plan with a UK EMI sub-plan, which is the mirror image of what most companies had before.

Staff who relocate between grant and exercise have their gains split by UK and US workdays over the relevant period. EMI relief protects only the UK-attributable portion, and the US taxes its share under its own rules. Founders and early employees who move to the US after grant are the group most often caught by this.

Your team's options do not automatically carry over. Once the parent takes control there are two routes: exercise within 90 days, or reissue options over the new parent within six months at matching value and matching exercise price. Decide which one applies to which people, and diarise the date control passes.

Should the IP move to the parent?

Most flips leave the intellectual property in the UK company. Keeping it there avoids an immediate IP transfer and may preserve Patent Box access where the conditions are met. It can align ownership with where the development work happens, though IP ownership does not itself determine which company can claim R&D relief.

That said, it is a decision rather than a default. US counsel and investors sometimes assume the IP belongs in the parent, and if the customers, contracts, team and next investor are all in the US, there can be good commercial reasons for it to sit there.

Moving it has a price. IP held by a UK company sits within the corporate intangibles regime in CTA 2009 Part 8. A transfer between a company and a related party is treated for tax purposes as taking place at market value under CTA 2009 s 845, and the terms are subject to transfer pricing under TIOPA 2010 Part 4. The later the move, the higher the value and the larger the charge, which is an argument for deciding early. A middle route is to keep legal ownership in the UK and licence to the US parent on arm's length terms.

Sort out chain of title before the flip rather than during it. Diligence tests whether the company owns what it thinks it owns, and the same gaps come up again and again. A founder wrote the first version of the product before the company existed and never formally assigned it. A founder built it while employed or studying somewhere else, so a former employer or a university may have a claim. A contractor was engaged on a two-page agreement with no IP assignment clause.

Fixing those has a tax dimension. Tidying up title can involve a disposal of IP by an individual to a connected company at market value, which costs a good deal less before a US round has priced the business.

Where is the Delaware parent tax resident, and what about the PE?

A Delaware corporation is US resident by incorporation. It is also UK resident if its central management and control is exercised in the UK, which is a real possibility where a board of UK-resident founders takes the strategic decisions.

The UK/US treaty does not tie-break dual-resident companies by place of incorporation. Article 4(5) provides that the competent authorities will endeavour to determine residence by mutual agreement, and that failing such agreement the company is not entitled to treaty benefits except under limited articles [7]. Dual residence is not a technicality that resolves itself.

If the parent is intended to be US-only, its management and control needs genuinely to sit outside the UK. Holding board meetings abroad helps but is not conclusive, and the test looks at where decisions are actually taken rather than where they are minuted.

Here is where it gets awkward. Advice on a flip sometimes aims at eliminating the parent's UK presence altogether, treating any UK footprint as an exposure. But SEIS, EIS and EMI each require the parent to have a UK permanent establishment to qualify. Governance designed to strip out the parent's UK presence can cut straight across the reliefs you promised your investors and the option scheme you promised your team.

Three things get collapsed into one in these conversations, and they are not the same. Board location goes to corporate residence through central management and control. It does not determine whether a permanent establishment exists. A UK subsidiary does not, by itself, give its foreign parent a UK permanent establishment. And a permanent establishment that satisfies an incentive scheme's condition does not automatically answer a different question under the corporation tax or R&D rules.

You will sometimes hear that dual residence is manageable while a company is pre-revenue. It still leaves filing obligations, loss treatment, transfer pricing, R&D claims, and a residence question that gets considerably more expensive at exit.

Which company can claim R&D relief afterwards?

A flip does not itself decide which company can claim. Under the reformed contracted-out R&D rules, the answer depends on what R&D was intended or contemplated, the contractual arrangements, and whether the customer is within the charge to UK tax in relation to the activity under which the R&D was contracted out.

If the Delaware parent is outside that charge, a UK subsidiary carrying out the R&D may be able to claim on its own qualifying expenditure; HMRC's guidance addresses this position [8]. If the parent is within the relevant UK tax charge, the position needs separate analysis. Having a UK presence, or a permanent establishment that satisfies a different regime's conditions, does not settle it.

A claimant with little direct UK payroll may also run into the PAYE and NIC cap on a payable credit, though certain connected contractor and externally provided worker PAYE and NIC can come into that calculation. Moving people onto another group payroll or an employer-of-record arrangement changes the category and amount of qualifying expenditure. It does not automatically strip every cost out of a UK claim. Model the operating arrangements before you change the employment and intercompany contracts.

First-time claimants also need to watch the claim notification requirement, which runs to six months after the end of the period.

The intercompany agreement matters here, though not because a label in it picks the winner. It matters because the document should reflect the actual decisions, the real economic arrangements and the work that was done. Those are the facts the analysis turns on.

Which elections and deadlines apply?

Each of these usually sits with a different adviser, which is why they get missed. Check each against the current statutory wording rather than taking it from a checklist, including this one.

Two notes on s 431. It applies to restricted securities generally, not only to shares subject to vesting, and Delaware founder stock often carries reverse vesting and leaver provisions imposed by US investors. Those warrant a look. Whether other terms, such as rights of first refusal or drag rights, amount to relevant restrictions, and whether an election is appropriate, depends on the terms and the facts. It does not follow automatically. On whether elections made on the old UK shares carry across on an exchange, practice is to make a protective election on the new shares rather than rely on the answer.

Spare a thought for the US citizen founder living in the UK. A 14-day s 431 deadline and a 30-day §83(b) deadline run at the same time on the same shares, under two systems, with nothing joining them up.

In what order should a flip happen?

You can execute every step above correctly and still lose a relief, because the steps happened in the wrong order. A sequence that works:

1. Decide. Flip when a US investor makes it a condition, not before.
2. Tidy up. Documented share issues and filed SH01s, an accurate register of members, s 431 elections where appropriate, ERS returns filed, EMI grants notified and valuations on file, SEIS and EIS compliance statements and certificates, IP assignments from founders, contractors and any former employer or university, current confirmation statements and PSC register, corporation tax, VAT and PAYE up to date, and any informal equity promises formalised or resolved.
3. Design. Mirror-image share structure, with a pre-flip subdivision if needed. Keep the Delaware entity holding subscriber shares only. Plan the option treatment and the post-flip equity plan. Decide where the IP sits.
4. Value. Agree the valuation basis for stamp duty, for the exchange, for the §409A and for any EMI replacement.
5. Clear. Obtain the s 138 clearance before the exchange, noting its role as a condition of SEIS and EIS continuity, and consider a separate s 701 application where relevant. HMRC has 30 days; the lawyers draft in parallel.
6. Analyse the raise. Where financing forms part of the arrangements, apply the s 77A control test on its actual terms and document the chronology and the valuation evidence. An artificial time gap is not a universal answer.
7. Sign and complete the share exchange.
8. Stamp. Submit for adjudication claiming s 77 relief. If relief is unavailable, pay within 30 days of execution.
9. Elections. s 431 within 14 days on restricted new shares where appropriate; §83(b) within 30 days for any US taxpayers.
10. Options. Identify the disqualifying-event date. Decide whether exercise within 90 days is permitted and appropriate, or whether qualifying replacements are needed within six months, and report through the ERS return by the following 6 July.
11. Operate. Document the real intercompany model, determine the R&D claimant from the contracts, the decision-making and the relevant UK tax charge, and maintain the UK permanent establishment where SEIS, EIS and EMI depend on it.

What should a founder do now?

The problem in most flips is not bad legal work. US counsel generally execute the transaction competently. It is the hand-off that goes wrong. The US firm optimises the US position, the UK questions come back as "one for your UK tax adviser", and that happens after drafting has started rather than before it.

Here is an anonymised example of the shape it takes. A UK company flipped to Delaware ahead of a US round, advised by a top-tier US firm. The sequencing on the core exchange worked well: a pre-flip subdivision and register update completed before the clearance application went in, and the flip documents were drafted during HMRC's 30-day window. Counsel's advice on permanent establishment, though, treated a UK PE as a burden to be managed and suggested board meetings outside the UK, which addressed corporate residence rather than PE and did not engage with the incentive schemes' own UK PE conditions. The proposed funding instrument had features that would need checking against the SEIS and EIS share requirements before any UK angel relied on it. And the product had been built while the founders were degree apprentices with a large employer, so evidence of that employer's position on IP had to be found.

None of that is a criticism of the legal work. It is what falls between two sets of advisers.

Before you sign an exchange, test three things. Will the cap table still mirror after every change planned for completion? What does each existing investor's SEIS or EIS position depend on, and will the s 138 clearance be in hand in time? And what does the option timetable look like from the date control passes, employee by employee?

If a US term sheet is in front of you now, or you expect one, the Structure Review works through this on your own facts. The companion briefing on whether a UK company needs a Delaware entity to raise US investment covers the prior question of whether to flip at all, and the free Exposure Score is a reasonable first pass on where the structural pressure sits.

This article is general commentary and not advice, and no action should be taken on it without advice on the specific facts. Statutory references and HMRC guidance should be confirmed as current at the time of any transaction. Several areas covered here turn on the particular facts: whether an exchange meets the conditions for stamp duty acquisition relief, whether arrangements exist for the purposes of FA 1986 s 77A, where central management and control is exercised, whether a permanent establishment exists for the purposes of a given regime, and which company is entitled to claim R&D relief can each differ materially between transactions that look similar. US points, including §409A valuation practice, §83(b) elections and qualified small business stock eligibility, require US specialist advice.

Sources

1. Indicative market observation from US venture counsel speaking on the SeedLegals channel on the proportion of US-led rounds requiring a flip by stage. One practitioner's view rather than published research.
2. HMRC Venture Capital Schemes Manual, VCM16030 (EIS) and VCM37030 (SEIS), on the conditions for share exchange relief on the insertion of a new holding company, including the requirement for advance clearance under TCGA 1992 s 138. https://www.gov.uk/hmrc-internal-manuals/venture-capital-schemes-manual/vcm16030 · https://www.gov.uk/hmrc-internal-manuals/venture-capital-schemes-manual/vcm37030
3. Finance Act 2006 s 169, omitting the requirement in FA 1986 s 77(3)(a) that the acquiring company's registered office be in the United Kingdom, for instruments executed after the passing of that Act on 19 July 2006. https://www.legislation.gov.uk/ukpga/2006/25/section/169
4. HMRC Stamp Taxes on Shares Manual, STSM042410 on the s 77 conditions and STSM042460 on disqualifying arrangements under s 77A. https://www.gov.uk/hmrc-internal-manuals/stamp-taxes-shares-manual/stsm042410 · https://www.gov.uk/hmrc-internal-manuals/stamp-taxes-shares-manual/stsm042460
5. HMRC Employee Tax Advantaged Share Scheme User Manual, ETASSUM55030 on replacement option conditions, ETASSUM55040 on the six-month period, and ETASSUM57050 on exercise following a disqualifying event. https://www.gov.uk/hmrc-internal-manuals/employee-tax-advantaged-share-scheme-user-manual/etassum55030 · https://www.gov.uk/hmrc-internal-manuals/employee-tax-advantaged-share-scheme-user-manual/etassum55040 · https://www.gov.uk/hmrc-internal-manuals/employee-tax-advantaged-share-scheme-user-manual/etassum57050
6. HMRC guidance on enterprise management incentives, including the limits applying from 6 April 2026 and the removal of the grant notification requirement for options granted on or after 6 April 2027. https://www.gov.uk/government/collections/enterprise-management-incentives
7. UK/US Double Taxation Convention 2001, Article 4(5): residence of a dual-resident company to be determined by mutual agreement of the competent authorities, failing which the company is not entitled to treaty benefits except under limited articles. https://www.gov.uk/government/publications/usa-tax-treaties
8. HMRC Corporate Intangibles Research and Development Manual, CIRD161000 on contracted-out R&D under the merged scheme, and CIRD140000 on the PAYE and NIC cap. https://www.gov.uk/hmrc-internal-manuals/corporate-intangibles-research-and-development-manual/cird161000 · https://www.gov.uk/hmrc-internal-manuals/corporate-intangibles-research-and-development-manual/cird140000
9. HMRC Venture Capital Schemes Manual, VCM13030, on the permanent establishment requirement. https://www.gov.uk/hmrc-internal-manuals/venture-capital-schemes-manual/vcm13030

UK statutory and guidance references cited above: TCGA 1992 ss 10A, 135, 137, 138; ITA 2007 ss 180A, 247, 257HB, 698, 701; FA 1986 ss 77, 77A; FA 2006 s 169; Stamp Act 1891 s 55; ITEPA 2003 s 431 and Sch 5; CTA 2009 Part 8 and s 845; CTA 2010 Part 8A; TIOPA 2010 Part 4 and s 166; Companies Act 2006 s 641(2A). US references: IRC §§83(b), 409A, 422, 482, 1202.